Pets Anti-infective Drugs Market

Leptospirosis, staphylococcal infection, bacterial ear infection, actinomycosis, and nocardiosis are some of the most common forms of infections in pets. Moreover, pets are susceptible to bacterial diseases, such as plague, brucellosis, and Lyme disease. Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an organism infectious or by killing the infectious organism outright.This term encompasses antibiotics, antifungals etc.
Pets Anti-infective Drugs Market contains market size and forecasts of Pets Anti-infective Drugs in global, including the following market information:
Global Pets Anti-infective Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pets Anti-infective Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Pets Anti-infective Drugs companies in 2021 (%)
The global Pets Anti-infective Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
External Use Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pets Anti-infective Drugs include Zoetis, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva Sant? Animale, Vetoquinol, Nanjing Jindun Animal and Wuhan Chopperlvya, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pets Anti-infective Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pets Anti-infective Drugs Market, by Administration Method, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pets Anti-infective Drugs Market Segment Percentages, by Administration Method, 2021 (%)
External Use
Internal Use
Injection
Global Pets Anti-infective Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pets Anti-infective Drugs Market Segment Percentages, by Application, 2021 (%)
Dog
Cat
Others
Global Pets Anti-infective Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pets Anti-infective Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pets Anti-infective Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pets Anti-infective Drugs revenues share in global market, 2021 (%)
Key companies Pets Anti-infective Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Pets Anti-infective Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zoetis
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva Sant? Animale
Vetoquinol
Nanjing Jindun Animal
Wuhan Chopperlvya
Bimeda Animal Health
Ouro Fino Saude
Norbrook